for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Amyris Inc

AMRS.O

Latest Trade

4.99USD

Change

0.00(0.00%)

Volume

5,140,137

Today's Range

4.74

 - 

5.15

52 Week Range

4.34

 - 

23.42

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
4.99
Open
4.93
Volume
5,140,137
3M AVG Volume
144.53
Today's High
5.15
Today's Low
4.74
52 Week High
23.42
52 Week Low
4.34
Shares Out (MIL)
308.24
Market Cap (MIL)
1,538.11
Forward P/E
-6.68
Dividend (Yield %)
--

Next Event

Q4 2021 Amyris Inc Earnings Release

Latest Developments

More

Amyris Closes Upsized Offering Of $690.0 Mln Of 1.50% Convertible Senior Notes Due 2026

Amyris Prices $600 Million Of 1.50% Convertible Senior Notes Due 2026

Amyris To Offer $400.0 Mln Of Convertible Senior Notes Due 2026

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Amyris Inc

Amyris, Inc. is a synthetic biotechnology company. The Company applies its Lab-to-Market biotechnology platform to engineer, manufacture and market high performance, natural and sustainably sourced products using its computational tools, strain construction tools, screening and analytics tools, and advanced lab automation and data integration. The Company's biotechnology platform enables users to rapidly engineer microbes and use them as catalysts to metabolize renewable, plant-sourced sugars into high-value ingredients that it manufactures at industrial scale. Through the combination of its biotechnology platform and industrial fermentation process, the Company has developed, produced, and commercialized many distinct molecules. The Company is focused on three market areas, Health & Wellness, Clean Beauty and Flavor & Fragrance.

Industry

Chemical Manufacturing

Contact Info

5885 Hollis St Ste 100

EMERYVILLE, CA

94608-2405

United States

+1.510.4500761

https://www.amyris.com/

Executive Leadership

Geoffrey M. Duyk

Independent Interim Chairman of the Board

John G. Melo

President, Chief Executive Officer, Director

Han Kieftenbeld

Chief Financial Officer, Chief Administrative Officer

Eduardo Alvarez

Chief Operating Officer

Nicole Kelsey

General Counsel, Secretary

Key Stats

1.67 mean rating - 6 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

0.1K

2019

0.2K

2020

0.2K

2021(E)

0.3K
EPS (USD)

2018

-3.440

2019

-2.670

2020

-1.880

2021(E)

-0.955
Price To Earnings (TTM)
--
Price To Sales (TTM)
4.31
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
-556.43
Return on Equity (TTM)
-111.08

Latest News

Latest News

BRIEF-Amyris Inc Says Files For Offer And Sale Of Up To 35.51 Mln Shares Of Common Stock by The Selling Stockholders

* AMYRIS INC SAYS FILES FOR OFFER AND SALE OF UP TO 35.51 MILLION SHARES OF COMMON STOCKBY THE SELLING STOCKHOLDERS - SEC FILING Source text : (https://bit.ly/2LooEbS) Further company coverage:

BRIEF-Amyris Receives Approval To Sell Its Fermented Sugarcane Reb M In Brazil And Canada

* PRESS RELEASE - AMYRIS RECEIVES APPROVAL TO SELL ITS FERMENTED SUGARCANE REB M IN BRAZIL AND CANADA

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up